RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 83 filers reported holding RAPT THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.23 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $513,558 | -11.1% | 30,900 | 0.0% | 0.00% | – |
| Q2 2023 | $577,830 | +1.9% | 30,900 | 0.0% | 0.00% | – |
| Q1 2023 | $567,015 | -7.3% | 30,900 | 0.0% | 0.00% | – |
| Q4 2022 | $611,820 | -9.5% | 30,900 | +10.0% | 0.00% | – |
| Q3 2022 | $676,000 | +31.8% | 28,100 | 0.0% | 0.00% | – |
| Q2 2022 | $513,000 | -17.0% | 28,100 | 0.0% | 0.00% | – |
| Q1 2022 | $618,000 | -39.9% | 28,100 | +0.4% | 0.00% | – |
| Q4 2021 | $1,028,000 | +18.3% | 28,000 | 0.0% | 0.00% | – |
| Q3 2021 | $869,000 | -2.4% | 28,000 | 0.0% | 0.00% | – |
| Q2 2021 | $890,000 | +174.7% | 28,000 | +91.8% | 0.00% | – |
| Q1 2021 | $324,000 | +12.5% | 14,600 | 0.0% | 0.00% | – |
| Q4 2020 | $288,000 | -38.7% | 14,600 | 0.0% | 0.00% | – |
| Q3 2020 | $470,000 | +22.7% | 14,600 | +10.6% | 0.00% | – |
| Q2 2020 | $383,000 | – | 13,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 2,680,621 | $53,076,296 | 17.67% |
| Euclidean Capital LLC | 432,900 | $8,571,420 | 8.02% |
| GREAT POINT PARTNERS LLC | 1,436,569 | $28,444,066 | 5.58% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 880,000 | $17,424,000 | 3.47% |
| Trustees of Columbia University in the City of New York | 73,383 | $1,453 | 3.00% |
| Cheyne Capital Management (UK) LLP | 71,828 | $1,422,194 | 2.48% |
| Deep Track Capital, LP | 1,304,940 | $25,837,812 | 1.08% |
| Ghost Tree Capital, LLC | 125,000 | $2,475,000 | 1.06% |
| Perceptive Advisors | 1,798,955 | $35,619,309 | 1.00% |
| BRAIDWELL LP | 1,000,000 | $19,800,000 | 0.66% |